Atrial Fibrillation Market Expected to Generate Revenue of USD 48.82 Billion by 2030, Globally at a CAGR of 12.3%: Verified Market Research®

The prevalence of obesity and cardiovascular disease is increasing rapidly worldwide. Adoption of unhealthy and hectic lifestyle, rapid increase in heart diseases, are the factors driving the atrial fibrillation market.

CITY OF JERSEYNew Jersey , November 9, 2022 /PRNewswire/ — Verified Market Research recently released a report, “Atrial Fibrillation Market” By procedures (pharmacological drugs, non-pharmacological treatment) and by geography.

According to an in-depth study conducted by Verified Industry Research on the Atrial Fibrillation Market, the market size was valued at $17.28 billion in 2021 and is expected to reach $48.82 billion by 2030, growing at a CAGR of 12.3% from 2022 to 2030.

Download the PDF brochure:

Browse the table of contents in depth on “Atrial Fibrillation Market”

202 – Pages
126 – Tables
37 – Numbers

Global Atrial Fibrillation Market Overview

Atrial fibrillation is a medical condition that occurs due to abnormal and faulty electrical activities in the atria of the heart. It is a form of cardiac arrhythmia. Generally, atrial fibrillation has no symptoms that can be specifically related to the disease. But in general, it can be identified by symptoms such as fainting, palpitations, congestive heart failure or chest discomfort. Patients with such symptoms can consult the doctor for an ECG which may indicate atrial fibrillation. Depending on the severity of the condition, it is classified into three categories, paroxysmal, persistent and permanent severity. The WHO has stated that atrial fibrillation is the most common form of cardiac arrhythmia. Patients with atrial fibrillation have a much higher chance of producing blood clots that can lead to stroke.

With the growth of the geriatric population, the prevalence of atrial fibrillation has increased dramatically. This created a demand for catheter ablation for cardiac rehabilitation. For this reason, the atrial fibrillation market has also witnessed significant growth in recent years. During the forecast period, with a perfect balance between medical devices used for atrial fibrillation and drugs, the atrial fibrillation market is expected to grow exponentially.

Additionally, increased prevalence of strokes, brain damage, and atrial fibrillation caused by blood clots, along with an expanding elderly population, are driving the expansion of the global atrial fibrillation market. Technological developments in microwave and radiofrequency catheter ablation, along with the increased prevalence of disorders caused by lifestyle choices such as drinking and smoking, are expected to further drive the market growth.

Key players

The main market players are AtriCure Inc., Boston Scientific Corporation, Boehringer Ingelheim GmbH, Biosense Webster Inc., St. Jude Medical Inc., Johnson & Johnson Ltd., CardioFocus Inc., Sanofi-Aventis, Endoscopic Technologies Inc. and Bristol-Myers Squibb Corporation.

Verified Market Research has segmented the global atrial fibrillation market on the basis of procedures and geography.

  • Atrial Fibrillation Market, By Procedures
    • Pharmacological drugs
      • Anti-arrhythmic drugs
      • Anticoagulant drugs
    • Non-pharmacological treatment
      • Catheter ablation procedures
      • Radio frequency
      • HIFU
      • Cryoablation
      • Others
    • Labyrinth surgery
    • Electric cardioversion
  • Atrial Fibrillation Market, By Geography
    • North America
    • Europe
      • Germany
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • LINE
      • Middle East & Africa
      • Latin America

Browse related reports:

Electrophysiology Devices Market By Product Type (EP Ablation Catheters, EP Diagnostic Catheters), By Indication (Atrial Fibrillation (AF), Wolff-Parkinson-White (WPW) Syndrome), By End-User (Hospitals, diagnostic centers), by geography, and forecast

Implantable Cardiac Monitor Market by Type of Indication (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy and Unexplained Falls), by End User (Hospitals, Ambulatory Surgery Centers and Cardiac Center and Clinics), by Geography and Forecast

Atrial Fibrillation Surgery Market By Procedure (Catheter Ablation Procedures, Surgical/Maze Ablation Procedures), By Product (Catheter Ablation Products Market, Surgical Ablation Market), By Geography and forecasts

Atrial Fibrillation Drugs Market by Product (Antiarrhythmic Drugs, Anticoagulant Drugs), by Type (Paroxysmal, Permanent, Persistent) by Geography and Forecast

Top Cardiac Catheter Sensor Companies Are Fueling the Halted Healthcare Industry

Visualize the Atrial Fibrillation Market using Verified Market Intelligence -:

Verified market intelligence is our BI-enabled platform for storytelling in this market. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, segment and key players in your market. Present your market report and results with built-in presentation functionality that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D, and product development. VMI enables data delivery in Excel and interactive PDF formats with over 15 key market indicators for your market.

About Us

Verified Market Research is a leading global research and advisory firm serving over 5,000 clients. Verified Market Research provides advanced analytical research solutions while offering information-enriched research studies. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance use industry techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study over 14 categories across Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, automotive and transportation, information and communication technology, software and services, information security, mining, minerals and metals, construction. & construction, agricultural industry and medical devices from more than 100 countries.

Contact us
Mr. Edwyne Fernandes
Verified Market Research®
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768
E-mail: [email protected]
The Web:
Follow us: LinkedIn | Twitter


SOURCE Verified Market Research

Comments are closed.